Europe DNA Sequencing 麻豆原创 2021-2031 by Offering , Sequencing Type , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0322035

Publication Date:

March 31, 2022

Pages:

109

Publisher:

Grace 麻豆原创 Data

Countries:

Europe [1]

USD 2,880.00

Research & Development (Pharma & Healthcare) [2]

IT & eHealth [3]

Pharma & Healthcare [4]

Description:

Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.
Highlighted with 32 tables and 57 figures, this 109-page report 鈥淓urope DNA Sequencing 麻豆原创 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments
鈥� Consumables
鈥� Sequencing Services

Based on Sequencing Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Sanger Sequencing
鈥� Next Generation Sequencing
鈥� Other Sequencing Types

By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Sequencing by Synthesis
鈥� Ion Semiconductor Sequencing
鈥� Chain Termination Sequencing
鈥� Pyrosequencing
鈥� Sequencing by Ligation (SBL)
鈥� Single-Molecule Real-Time Sequencing (SMRT)
鈥� Nanopore Sequencing
鈥� Other Technologies

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Biomarker Discovery
鈥� Diagnostics
鈥� Personalized Medicine
鈥� Reproductive Health
鈥� Forensics
鈥� Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Academics and Research Organizations
鈥� Pharmaceutical and Biotechnology Companies
鈥� Hospitals & Clinics
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Russia
鈥� Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 31
2.4 Emerging Opportunities and 麻豆原创 Trends 34
2.5 Porter鈥檚 Fiver Forces Analysis 38
3 Segmentation of Europe 麻豆原创 by Offering 42
3.1 麻豆原创 Overview by Offering 42
3.2 Instruments 44
3.3 Consumables 45
3.4 Sequencing Services 46
4 Segmentation of Europe 麻豆原创 by Sequencing Type 47
4.1 麻豆原创 Overview by Sequencing Type 47
4.2 Sanger Sequencing 49
4.3 Next Generation Sequencing 50
4.4 Other Sequencing Types 51
5 Segmentation of Europe 麻豆原创 by Technology 52
5.1 麻豆原创 Overview by Technology 52
5.2 Sequencing by Synthesis 54
5.3 Ion Semiconductor Sequencing 55
5.4 Chain Termination Sequencing 56
5.5 Pyrosequencing 57
5.6 Sequencing by Ligation (SBL) 58
5.7 Single-Molecule Real-Time Sequencing (SMRT) 59
5.8 Nanopore Sequencing 60
5.9 Other Technologies 61
6 Segmentation of Europe 麻豆原创 by Application 62
6.1 麻豆原创 Overview by Application 62
6.2 Biomarker Discovery 64
6.3 Diagnostics 65
6.4 Personalized Medicine 66
6.5 Reproductive Health 67
6.6 Forensics 68
6.7 Other Applications 69
7 Segmentation of Europe 麻豆原创 by End User 70
7.1 麻豆原创 Overview by End User 70
7.2 Academics and Research Organizations 72
7.3 Pharmaceutical and Biotechnology Companies 73
7.4 Hospitals & Clinics 74
7.5 Other End Users 75
8 European 麻豆原创 2021-2031 by Country 76
8.1 Overview of European 麻豆原创 76
8.2 Germany 79
8.3 U.K. 81
8.4 France 83
8.5 Spain 85
8.6 Italy 87
8.7 Russia 89
8.8 Rest of European 麻豆原创 91
9 Competitive Landscape 93
9.1 Overview of Key Vendors 93
9.2 New Product Launch, Partnership, Investment, and M&A 96
9.3 Company Profiles 97
Agilent Technologies Inc. 97
BGI Genomics Co., Ltd. 99
Bio-Rad Laboratories Inc. 100
Danaher Corporation (Integrated DNA Technologies Inc.) 101
Eurofins Scientific SE 102
F. Hoffmann-La Roche Ltd. 103
Illumina Inc. 104
Merck KGaA 105
Pacific Biosciences of California Inc. 106
PerkinElmer Inc. 107
Thermo Fisher Scientific Inc. 108
RELATED REPORTS 109

Companies Mentioned:

Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.